Management of GERD
Start all patients with troublesome heartburn or regurgitation on a 4-8 week trial of once-daily proton pump inhibitor (PPI) therapy, which is the most effective medical treatment for GERD. 1, 2
Initial Pharmacologic Management
PPIs are superior to H2-receptor antagonists (H2RAs), which are superior to placebo for both healing esophagitis and providing symptomatic relief 1. This represents Grade A evidence—the strongest recommendation level.
Dosing Algorithm:
- Start: Once-daily PPI for 4-8 weeks 2
- If inadequate response: Increase to twice-daily PPI or switch to a different PPI once daily 2
- Upper limit of empirical therapy: Twice-daily PPI; patients not responding at this dose are treatment failures and require diagnostic evaluation 1
Important caveat: Most clinical trial data support once-daily dosing, but expert consensus unanimously recommends twice-daily dosing for inadequate responders based on pharmacodynamic principles 1.
Lifestyle Modifications: Tailored, Not Universal
Do not broadly recommend all lifestyle changes to every patient—insufficient evidence supports this approach 1. Instead, apply modifications selectively based on individual patient circumstances:
Grade B Recommendations (Fair Evidence):
- Weight loss: Strongly advised for overweight/obese patients 1
- Head of bed elevation: For patients with nighttime heartburn or regurgitation despite acid suppression 1
Individualized Recommendations:
- Avoid trigger foods (coffee, alcohol, chocolate, fatty foods, citrus, carbonated drinks, spicy foods) only if the patient consistently experiences symptoms after consuming them 1, 3
- Avoid recumbency 2-3 hours after meals for patients with postprandial symptoms 1
- Smoking cessation 1, 3
- Left-lateral sleep position 3
Long-Term Maintenance Therapy
For Erosive Esophagitis:
Continuous daily PPI therapy is strongly recommended (Grade A) to maintain healed mucosa 1. Titrate to the lowest effective dose based on symptom control 1.
Do not use less-than-daily dosing in patients with previously documented erosive esophagitis—recurrence rates are unacceptably high (Grade D recommendation against) 1.
For Non-Erosive GERD:
On-demand PPI therapy is reasonable when symptom control is the primary objective 1. These patients can often manage with intermittent dosing.
When to Perform Diagnostic Testing
Obtain objective testing with endoscopy and/or prolonged wireless pH monitoring off PPI in these situations 2:
- Long-term PPI therapy planned (offer testing within 12 months of initiation)
- Inadequate response to twice-daily PPI
- Alarm symptoms present (dysphagia, weight loss, bleeding, anemia)
- Isolated extraesophageal symptoms (chronic cough, laryngitis, asthma)
- Patients meeting Barrett's esophagus screening criteria
For isolated extraesophageal symptoms, perform upfront objective testing off medication rather than empirical PPI trial 2.
Complete Endoscopic Evaluation Includes:
- Los Angeles classification of erosive esophagitis
- Hill grade of flap valve at diaphragmatic hiatus
- Axial hiatus hernia length measurement
- Prague classification and biopsy of Barrett's esophagus if present 2
Medications to Avoid
Do not use metoclopramide as monotherapy or adjunctive therapy for GERD—Grade D recommendation against due to ineffectiveness and potential harms outweighing benefits 1.
Do not add nocturnal H2RA to twice-daily PPI—no evidence of improved efficacy 1.
Safety and De-escalation
Emphasize PPI safety to patients 2. The main risk of reducing or discontinuing therapy is increased symptom burden, not disease progression 1. Continuous antisecretory therapy does not alter GERD's natural history except for reducing peptic stricture incidence (already low) 1.
Titrate to lowest effective dose once symptoms are controlled 1, 2. The decision for maintenance therapy dosage is driven by impact on quality of life rather than disease control 1.
Refractory Cases
Patients failing twice-daily PPI require:
- Confirmation of diagnosis with objective testing
- Assessment for functional esophageal disorders if normal acid exposure
- Consideration of surgical/endoscopic interventions for confirmed severe GERD
- Evaluation for overlapping functional disorders requiring neuromodulators or behavioral interventions 2, 4
Common pitfall: Many patients on long-term PPI for "GERD" ultimately have a different diagnosis requiring alternative treatment 5. Diagnostic confirmation prevents years of inappropriate therapy.